Jefferies Financial Group cut shares of R1 RCM (NASDAQ:RCM – Free Report) from a buy rating to a hold rating in a research note released on Thursday morning, Marketbeat reports.
RCM has been the topic of a number of other research reports. Canaccord Genuity Group reissued a buy rating and issued a $15.00 price target on shares of R1 RCM in a research note on Monday, July 22nd. KeyCorp restated a sector weight rating on shares of R1 RCM in a research report on Wednesday, April 10th. Royal Bank of Canada restated an outperform rating and issued a $19.00 price objective on shares of R1 RCM in a research report on Friday, June 28th. Cantor Fitzgerald restated an overweight rating and issued a $20.00 price objective on shares of R1 RCM in a research report on Tuesday, July 2nd. Finally, Robert W. Baird restated an outperform rating and issued a $18.00 price objective on shares of R1 RCM in a research report on Tuesday, July 2nd. Ten research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of Hold and an average target price of $16.02.
View Our Latest Stock Report on R1 RCM
R1 RCM Trading Down 0.1 %
R1 RCM (NASDAQ:RCM – Get Free Report) last released its quarterly earnings data on Wednesday, May 8th. The healthcare provider reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The company had revenue of $603.90 million during the quarter, compared to the consensus estimate of $612.88 million. R1 RCM had a negative net margin of 1.39% and a negative return on equity of 1.16%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. On average, analysts expect that R1 RCM will post -0.2 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Privium Fund Management UK Ltd purchased a new stake in shares of R1 RCM during the 2nd quarter valued at approximately $502,000. CIBC Asset Management Inc purchased a new stake in shares of R1 RCM during the 2nd quarter valued at approximately $149,000. BW Gestao de Investimentos Ltda. lifted its stake in shares of R1 RCM by 14.9% during the 2nd quarter. BW Gestao de Investimentos Ltda. now owns 1,027,220 shares of the healthcare provider’s stock valued at $12,902,000 after buying an additional 133,324 shares in the last quarter. Pentwater Capital Management LP purchased a new stake in shares of R1 RCM during the 2nd quarter valued at approximately $2,512,000. Finally, Intact Investment Management Inc. purchased a new stake in R1 RCM in the 2nd quarter worth approximately $621,000. 61.10% of the stock is currently owned by hedge funds and other institutional investors.
R1 RCM Company Profile
R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.
Featured Stories
- Five stocks we like better than R1 RCM
- The 3 Best Retail Stocks to Shop for in August
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- Why Are Stock Sectors Important to Successful Investing?
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
- Health Care Stocks Explained: Why You Might Want to Invest
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.